With the prevalence of diabetes quadrupling in recent decades and currently impacting more than 500 million people in the world, it is no surprise that the technology for insulin delivery has also ...
Blood sugar levels improve when adults with type 1 diabetes use modern insulin pumps. These are the findings of a study conducted at the University of Gothenburg. Patients are also overwhelmingly ...
Cipla, a global name in inhalation therapies, has announced the launch of Afrezza, the world’s only rapid-acting inhaled insulin, in India. The drug is approved for adults with type 1 and type 2 ...
Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA granted 510(k) clearance for a tubeless insulin ...
Everyday Health on MSN
Do you still need insulin for type 2 diabetes in the Ozempic era?
Learn how GLP-1s are changing type 2 diabetes care, when insulin therapy is still necessary, and the benefits of combining ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results